Heartflow Financial Ratios
NASDAQ: HTFLHealth CareMedical/Dental InstrumentsUSD
49.74+2.11 (+4.43%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Heartflow ratio analysis
Heartflow earned a net margin of -66.3% in FY 2025, up from -76.6% a year earlier. Gross margin was 76.8% compared with a median of 70.8% over the prior 2 years. Return on equity reached -38.8%, meaning Heartflow generated -0.39 dollars of profit for every dollar of shareholders' equity.
Valuation ratios use the closing share price on each fiscal year-end date and diluted shares from the income statement; profitability and leverage ratios use reported annual figures. Current valuation multiples are on the statistics page.
Summary generated from market data by MetaCap's automated system. Methodology
Heartflow financial ratios (annual)
| Ratio | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|
| Price / sales | 6.07 | — | — |
| Price / book | 3.55 | — | — |
| Gross margin | 76.8% | 75.1% | 66.6% |
| Operating margin | -36.4% | -48.7% | -83.6% |
| Net margin | -66.3% | -76.6% | -109.7% |
| Free cash flow margin | -33.5% | -58.3% | -94.7% |
| Return on equity (ROE) | -38.8% | — | — |
| Return on assets (ROA) | -32.5% | -81.2% | — |
| Current ratio | 5.20 | 2.45 | — |
| Revenue growth | 39.9% | 44.3% | — |